Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

D-Dimer beyond Diagnosis of Pulmonary Embolism: Its Implication for Long-Term Prognosis in Cardio-Oncology Era.

Autor: Himeno M; Department of Cardiology, National Defense Medical College, Tokorozawa 359-8513, Japan., Nagatomo Y; Department of Cardiology, National Defense Medical College, Tokorozawa 359-8513, Japan., Miyauchi A; Department of Cardiology, National Defense Medical College, Tokorozawa 359-8513, Japan., Sakamoto A; Department of Cardiology, National Defense Medical College, Tokorozawa 359-8513, Japan., Kiyose K; Department of Cardiology, National Defense Medical College, Tokorozawa 359-8513, Japan., Yukino-Iwashita M; Department of Cardiology, National Defense Medical College, Tokorozawa 359-8513, Japan., Kawai A; Department of Cardiology, National Defense Medical College, Tokorozawa 359-8513, Japan., Naganuma T; Department of Cardiology, National Defense Medical College, Tokorozawa 359-8513, Japan., Maekawara S; Department of Cardiology, National Defense Medical College, Tokorozawa 359-8513, Japan., Naito A; Department of Cardiology, National Defense Medical College, Tokorozawa 359-8513, Japan., Kagami K; Department of Cardiology, National Defense Medical College, Tokorozawa 359-8513, Japan., Yumita Y; Department of Cardiology, National Defense Medical College, Tokorozawa 359-8513, Japan., Yasuda R; Department of Cardiology, National Defense Medical College, Tokorozawa 359-8513, Japan., Toya T; Department of Cardiology, National Defense Medical College, Tokorozawa 359-8513, Japan., Ikegami Y; Department of Cardiology, National Defense Medical College, Tokorozawa 359-8513, Japan., Masaki N; Department of Cardiology, National Defense Medical College, Tokorozawa 359-8513, Japan., Adachi T; Department of Cardiology, National Defense Medical College, Tokorozawa 359-8513, Japan.

Publikováno v: Journal of personalized medicine [J Pers Med] 2023 Jan 27; Vol. 13 (2). Date of Electronic Publication: 2023 Jan 27.

Novel neutralizing human monoclonal antibodies against tetanus neurotoxin.

Autor: Minamitani T; Laboratory of Infectious Diseases and Immunity, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), 7-6-8 Saito-Asagi, Ibaraki City, Osaka, 567-0085, Japan.; Laboratory of Immunobiologics Evaluation, Center for Vaccine and Adjuvant Research (CVAR), National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), 7-6-8 Saito-Asagi, Ibaraki City, Osaka, 567-0085, Japan., Kiyose K; Laboratory of Infectious Diseases and Immunity, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), 7-6-8 Saito-Asagi, Ibaraki City, Osaka, 567-0085, Japan.; Laboratory of Immunobiologics Evaluation, Center for Vaccine and Adjuvant Research (CVAR), National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), 7-6-8 Saito-Asagi, Ibaraki City, Osaka, 567-0085, Japan., Otsubo R; Laboratory of Pharmaceutical Integrated Omics, Department of Pharmaceutical Engineering, Facility of Engineering, Toyama Prefectural University, 5180 Kurokawa, Imizu, Toyama, 939-0398, Japan., Ito T; Laboratory of Proteome Research, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), 7-6-8 Saito-Asagi, Ibaraki City, Osaka, 567-0085, Japan., Akiba H; Laboratory of Advanced Biopharmaceuticals, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), 7-6-8 Saito-Asagi, Ibaraki City, Osaka, 567-0085, Japan., Furuta RA; Japanese Red Cross Central Blood Institute, 1-67 Tatsumi, Koto-ku, Tokyo, 135-8521, Japan., Inoue T; Division of Advance Pharmaco-Science, Graduate School of Pharmaceutical Science, Osaka University, 1-6 Yamada-oka, Suita, Osaka, 565-0871, Japan., Tsumoto K; Center for Drug Discovery Research (CDDR), National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), 7-6-8 Saito-Asagi, Ibaraki City, Osaka, 567-0085, Japan.; Medical Proteomics Laboratory, The Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo, 108-8639, Japan.; Department of Bioengineering, School of Engineering, The University of Tokyo, 7-3-1 Hongo, Bunkyo-Ku, Tokyo, 113-8656, Japan., Satake M; Japanese Red Cross Central Blood Institute, 1-67 Tatsumi, Koto-ku, Tokyo, 135-8521, Japan., Yasui T; Laboratory of Infectious Diseases and Immunity, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), 7-6-8 Saito-Asagi, Ibaraki City, Osaka, 567-0085, Japan. tyasui@nibiohn.go.jp.; Laboratory of Immunobiologics Evaluation, Center for Vaccine and Adjuvant Research (CVAR), National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), 7-6-8 Saito-Asagi, Ibaraki City, Osaka, 567-0085, Japan. tyasui@nibiohn.go.jp.; Laboratory of Pharmaceutical Integrated Omics, Department of Pharmaceutical Engineering, Facility of Engineering, Toyama Prefectural University, 5180 Kurokawa, Imizu, Toyama, 939-0398, Japan. tyasui@nibiohn.go.jp.

Publikováno v: Scientific reports [Sci Rep] 2021 Jun 09; Vol. 11 (1), pp. 12134. Date of Electronic Publication: 2021 Jun 09.

Design and Synthesis of an Azo Reductase Responsive Flavonol–Indomethacin Hybrid Used for the Diagnosis and Treatment of Colitis.

Autor: Gu, Yaqin¹ (AUTHOR) guyaqin@jsmc.edu.com, Yang, Rui¹ (AUTHOR) 12359@jsmc.edu.cn, Chen, Jine¹ (AUTHOR) eee214@sina.com, Fan, Yu² (AUTHOR) fanyu_1998@sina.com, Xie, Wenna¹ (AUTHOR) xiewenna_ch@163.com, Wu, Hongyan¹ (AUTHOR) wuhongyan@jsmc.edu.cn, Ding, Jinfeng¹ (AUTHOR) 11978@jsmc.edu.cn

Publikováno v: Molecules. Sep2024, Vol. 29 Issue 17, p4244. 17p.

Efficacy, Safety, and Tolerability of Switching from Oral Cholinesterase Inhibitors to Rivastigmine Transdermal Patch with 1-Step Titration in Patients with Mild to Moderate Alzheimer's Disease: A 24-Week, Open-Label, Multicenter Study in Japan.

Autor: Ueda K; Novartis Pharma K.K., Tokyo, Japan., Katayama S; Katayama Medical Clinic, Okayama, Japan., Arai T; Faculty of Medicine, University of Tsukuba, Ibaraki, Japan., Furuta N; Yokufukai Hospital, Tokyo, Japan., Ikebe S; Ikebe Clinic, Shizuoka, Japan., Ishida Y; Takeda General Hospital, Fukushima, Japan., Kanaya K; Hachioji Medical Center, Geriatric Medicine, Tokyo Medical University, Tokyo, Japan., Ouma S; Department of Neurology, Fukuoka University, Fukuoka, Japan., Sakurai H; Department of Geriatric Medicine, Tokyo Medical University, Tokyo, Japan., Sugitani M; Sagamihara Kyodo Hospital, Kanagawa, Japan., Takahashi M; Department of Neurology, Osaka Red Cross Hospital, Osaka, Japan., Tanaka T; Department of Psychiatry, Osaka University Graduate School of Medicine, Osaka, Japan., Tsuno N; Department of Neuropsychiatry, Kagawa University School of Medicine, Kagawa, Japan., Wakutani Y; Department of Neurology, Kurashiki Heisei Hospital, Okayama, Japan., Shekhawat A; Novartis Healthcare Pvt. Ltd., Data Sciences, SSP, PLS, Hyderabad, India., Das Gupta A; Novartis Healthcare Pvt. Ltd., Data Sciences, SSP, PLS, Hyderabad, India., Kiyose K; Novartis Pharma K.K., Tokyo, Japan., Toriyama K; Novartis Pharma K.K., Tokyo, Japan., Nakamura Y; Department of Neuropsychiatry, Kagawa University School of Medicine, Kagawa, Japan.

Publikováno v: Dementia and geriatric cognitive disorders extra [Dement Geriatr Cogn Dis Extra] 2019 Aug 15; Vol. 9 (2), pp. 302-318. Date of Electronic Publication: 2019 Aug 15 (Print Publication: 2019).